The Challenge of lipid management in patients with diabetes or: Other endocrine disorders

Alberico L. Catapano, Liliana Grigore, Angela Pirillo

Research output: Contribution to journalArticlepeer-review


Diabetes increases the risk of developing cardiovascular disease (CVD), and several guidelines suggest that subjects with diabetes are at high risk of developing CVD. The increased risk can be attributed, at least in part, to associated risk factors, including hypertension and dyslipidaemia. The role of statins in primary and secondary prevention of CVD is well established, and the positive effect has been clearly demonstrated also in patients with type 2 diabetes. A number of studies have evaluated the effect of statin therapy on incident CVD and shown that statin therapy produces a great reduction in cardiovascular risk, but a recent meta-analysis revealed a slight increase in the risk of developing diabetes. Such risk is, however, low, especially when compared with the reduction in cardiovascular events and should not interfere with the choice of treating diabetic patients with a cholesterol-lowering therapy.

Original languageEnglish
Pages (from-to)92-95
Number of pages4
JournalEuropean Endocrinology
Issue number2
Publication statusPublished - 2011


  • Cardiovascular Risk
  • Combination thera py
  • Diabetes
  • Lipid-lowering
  • Low-density lipoprotein (LDL)
  • Statins

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Endocrine and Autonomic Systems


Dive into the research topics of 'The Challenge of lipid management in patients with diabetes or: Other endocrine disorders'. Together they form a unique fingerprint.

Cite this